In today’s Pharmaceutical Executive Daily, the FDA approves Hernexeos under a national priority voucher program, industry ...
Joseph Kleiman, president of Buzz Health, discusses the impact of Trump RX on transparency in drug pricing. In his ...
This episode of The Ron Lanton Report examines whether healthcare consolidation in the United States may be approaching a ...
The approval comes under the National Priority Voucher Program, joining Augmentin XR as one of the few approvals from the voucher program as of February 27, 2026. Hernexeos was granted a national ...
Significant PrEP underutilization remains, with ~600,000 US users versus an estimated 2.2 million who could benefit, largely due to low awareness, stigma, and misconceptions about HIV risk. Yeztugo is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results